Ticker: SKBI, Company: SKYSTAR BIO-PHARMACEUTICAL CO, Type: 8-K, Date: 2010-09-01
Original SEC Filing: Click here

---

Webplus: SKBI/20100901/8-K_1/2_EX-99.1/000.htm SEC Original: v195806_ex99-1.htm
NEWS RELEASE Skystar Bio-Pharmaceutical to Present at Rodman & Renshaw XI’AN, CHINA – September 1 , 2010 — – Skystar Bio-Pharmaceutical Company (NASDAQ:SKBI) (“Skystar” or the “Company”), announced that the Company will present at the skystar@grayling.com The conference will include a series of one-on-one meetings with institutional investors. Investors interested in scheduling a meeting with Mr. Weibing Lu and the

---

---

Webplus: SKBI/20100901/8-K_1/1/000.htm SEC Original: v195806_8k.htm
FORM 8-K CURRENT REPORT Date of report (Date of earliest event reported): September 1, 2010 SKYSTAR BIO-PHARMACEUTICAL COMPANY Nevada 001-34394 33-0901534 (State or other jurisdiction of incorporation or organization) (Commission File No.) (IRS Employer Identification No.) Rm. 10601, Jiezuo Plaza, No.4, Fenghui Road South, Gaoxin District, Xi’an, Shaanxi Province, P.R. China (8629) 8819-3188[ (Issuer Telephone Number) N/A (Former name or

---

Company Information:

Ticker: SKBI, Company: SKYSTAR BIO-PHARMACEUTICAL CO, Type: 8-K, Date: 2010-09-01CIK: 0001076939, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
RM 10601, JIEZUO PLAZA, NO. 4, FENGHUI ROAD SOUTH, GAOXIN DISTRICT
XIAN PROVINCE